Abstract

Acute lymphoblastic leukemia (ALL) is one of the most prevalent childhood cancers worldwide. Although the 5-year event-free survival rate of ALL patients have been improved to about 80% in latest years, there are approximately 15% of ALL cases in China remained to be poorly responsive to chemotherapy treatments, and therefore manifested in poor prognosis. Daunorubicin (DNR) is a key agent (Fig.1), as a chemical can cause DNA damages, in the formula for the treatments of ALL patients, the drug resistance to DNR will directly contributed to the failing of treatments and poor prognosis. In clinic, there is an urgent need for the development of assays that can be used for the prediction of DNR resistance, especially the involvement of visual indicators. Coilin is a major scaffold and marker protein of the functional nuclear structure - Cajal body (CB). We found that DNR was able to induce vast nucleolar accumulation of coilin in ALL leukemia cell lines of RS4;11 and Reh. Such accumulation of coilin was dose-dependently correlated to the increase of drug concentrations (Fig.2). At the molecular level, we also observed that the expression levels of coilin increased based on treatment of DNR(Fig.3B), while the expression levels of p27 protein was much lower in DNR insensitive cells with less significant changes of Coilin-indicated CB morphology as compared to the sensitive cells (Fig.3A). The over-expression of Coilin inhibited p27 expression and coilin knock-down increased the expression of p27(Fig.3 C,D). Our study suggested that coilin could be considered as a visual maker for the detection of daunorubicin resistance in ALL cells, and the mechanism possibly involved the regulation of drug sensitivity -related protein p27 through Cajal body -mediated RNA processing, during which coilin is an important participator with crucial functions.Results1.Daunorubicin inhibits topoisomerase II activity2.Daunorubicin(DNR)-induced DNA damage triggers the nucleolar accumulation of coilin3.Coilin inhibit the expression of p27 and may play a role in the drug resistance of leukemia through p27 [Display omitted] [Display omitted] [Display omitted] DisclosuresNo relevant conflicts of interest to declare.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.